ctrl K

Watchlist Price Alert

Adamis Pharmaceuticals Co... (ADMP)

NASDAQ: ADMP · Real-Time Price · USD

0.78

0.01 (1.50%)

At close: Sep 07, 2023, 7:59 PM

Adamis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	4.76M	2.21M	16.53M	22.11M	15.09M	13.07M	6.47M
Cost of Revenue	6.19M	6.87M	14.89M	15.48M	9.8M	7.42M	4.85M
Gross Profit	-1.43M	-4.66M	1.63M	6.64M	5.29M	5.65M	1.62M
Operating Income	-25.06M	-32.07M	-37.23M	-29.03M	-39.46M	-24.79M	-25.2M
Interest Income	44.13K	n/a	n/a	175.77K	245.4K	102.23K	9.29K
Pretax Income	-26.2M	-34.6M	-49.39M	-29.3M	-39.38M	-25.88M	-24.01M
Net Income	-26.2M	-34.6M	-49.39M	-29.31M	-39.01M	-25.54M	-19.44M
Selling & General & Admin	13.25M	16.14M	30.58M	25.29M	25.95M	22.82M	17.13M
Research & Development	10.38M	11.26M	8.28M	10.38M	18.79M	7.53M	9.7M
Other Expenses	-1.87M	7.22K	84.01K	n/a	n/a	-960.23K	n/a
Operating Expenses	23.63M	27.41M	38.86M	35.66M	44.74M	30.35M	26.82M
Interest Expense	44.13K	6.65K	159.63K	123.26K	157.76K	231.29K	214.4K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	29.82M	34.28M	53.76M	51.14M	54.54M	37.77M	31.68M
Income Tax Expense	2K	796.00	2.17K	8.67K	-369.34K	-339.39K	-4.57M
Shares Outstanding (Basic)	2.14M	2.06M	1.11M	760.91K	558.36K	404.99K	250.01K
Shares Outstanding (Diluted)	2.14M	2.06M	1.11M	760.91K	558.36K	404.99K	250.01K
EPS (Basic)	-12.24	-16.8	-44.57	-38.52	-69.86	-63.06	-77.75
EPS (Diluted)	-12.24	-16.8	-44.57	-38.52	-69.86	-63.06	-77.75
EBITDA	-24.27M	-30.63M	-33.54M	-25.91M	-36.11M	-22.49M	-22.66M
EBIT	-1.16B	-34.59M	339.76M	-28.85M	-39.22M	-25.65M	-23.8M
Depreciation & Amortization	791.34K	1.44M	3.69M	3.12M	3.1M	3.06M	2.53M